Related Experiment Video
Updated: Jul 1, 2026

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
Published on: June 7, 2015
Ultra-sensitive pH responsive hydrogels with injectable and self-healing performance for controlled drug delivery
Yang Yu1,2, Yili Zhao2, Yujiao Zou2
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
A novel pH-responsive hydrogel was developed for cancer therapy. This drug delivery system shows ultra-sensitive release of Doxorubicin in tumor microenvironments, enhancing chemotherapy effectiveness.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Cancer Therapy
Background:
- Developing pH-responsive hydrogels is crucial for targeted cancer therapy.
- Tumor microenvironments exhibit slightly acidic pH, ideal for targeted drug release.
Purpose of the Study:
- To synthesize and characterize an ultra-sensitive pH-responsive hydrogel for Doxorubicin delivery.
- To evaluate the hydrogel's performance in a simulated tumor microenvironment.
Main Methods:
- Synthesized 4-Formylbenzoic acid modified polyvinyl alcohol (PVA-FBA) and crosslinked with polyethylenimine (PEI) to form Doxorubicin-loaded PVA-FBA/PEI hydrogel (D-PFP).
- Characterized hydrogel properties, including structural stability, morphology, and drug release kinetics at different pH values (7.4 and 6.8).
- Assessed injectability, self-healing properties, cytocompatibility, and anticancer activity.
Main Results:
- Optimal hydrogel preparation conditions were identified using PF-0.25 polymer and specific precursor/PEI concentrations.
- The D-PFP hydrogel demonstrated minimal drug leakage at pH 7.4 and significantly higher release at pH 6.8, indicating high pH sensitivity.
- The hydrogel exhibited good structural integrity, injectability, self-healing capabilities, excellent cytocompatibility, and potent cancer cell inhibition.
Conclusions:
- The developed D-PFP hydrogel is an ultra-sensitive, pH-responsive drug delivery system.
- Its properties make it a promising candidate for targeted chemotherapy applications in cancer treatment.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Stimuli-Activated
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Ophthalmic Drug Delivery Systems
Intrauterine Drug Delivery Systems

